Related Experiment Video

Updated: Jul 16, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Statins and the effect of BCG on bladder cancer

Anna Orsola, Lluís Cecchini, Joaquim Bellmunt

    The New England Journal of Medicine
    |March 24, 2007
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    An Orthotopic Bladder Cancer Model for Gene Delivery Studies
    07:48

    An Orthotopic Bladder Cancer Model for Gene Delivery Studies

    Published on: December 1, 2013

    Related Experiment Videos

    Last Updated: Jul 16, 2026

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
    11:02

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

    Published on: October 30, 2013

    An Orthotopic Bladder Cancer Model for Gene Delivery Studies
    07:48

    An Orthotopic Bladder Cancer Model for Gene Delivery Studies

    Published on: December 1, 2013

    Related Concept Videos

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents

    Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    Machine learning-integrated explainable artificial intelligence for survival prediction in urothelial carcinoma with enfortumab vedotin: an exploratory real-world analysis.

    Expert opinion on biological therapy·2026

    Association between time from diagnosis to radical cystectomy and oncologic outcomes in muscle-invasive urothelial carcinoma of the bladder.

    Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026

    Extended vs Standard Lymph Node Dissection at the Time of Radical Cystectomy for Bladder Cancer.

    Urology·2026

    Evaluating the Surrogacy of Pathological Complete Response at Radical Cystectomy in Neoadjuvant-based Muscle-invasive Bladder Cancer Trials.

    European urology oncology·2026

    Epigenetic subtypes of high-grade T1 bladder cancer reveal intra-tumor heterogeneity and distinct interactions with tumor microenvironment.

    Theranostics·2026

    Tumor B-cell infiltration in platinum-treated advanced muscle-invasive urothelial carcinoma.

    Molecular oncology·2026

    Catheter-Directed Thrombolysis in Intermediate-High-Risk Pulmonary Embolism.

    The New England journal of medicine·2026

    Timing of PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation.

    The New England journal of medicine·2026

    Pulmonary Denervation for Heart Failure-Related Pulmonary Hypertension.

    The New England journal of medicine·2026

    Targeted Use of Computed Tomographic Coronary Angiography in Acute Chest Pain.

    The New England journal of medicine·2026

    Complete Revascularization Guided by Functional Coronary Angiography in STEMI.

    The New England journal of medicine·2026

    Immediate Ambulatory Electrocardiographic Monitoring in Syncope.

    The New England journal of medicine·2026

    CCT8 associates with the MYO10 motor domain and regulates filopodia and breast cancer cell invasion.

    Journal of cell science·2026

    Probiotic intervention in colorectal cancer: the cytotoxic and apoptotic potential of Lactobacillus cell-free supernatants.

    Turkish journal of biology = Turk biyoloji dergisi·2026

    Bisphenol A and ovarian cancer: emerging evidence and potential biological mechanisms.

    Frontiers in cell and developmental biology·2026

    Correction: Cell cycle dysregulation: a central hub in colitis-associated colorectal carcinogenesis.

    Frontiers in immunology·2026

    CircHMGA2 facilitates proliferation and invasion of laryngeal squamous cell carcinoma cells and M2 macrophage polarization via the miR-384/ROCK1 axis.

    Central-European journal of immunology·2026

    Mitochondrial transfer: a new perspective on tumor-microenvironment crosstalk driving metastasis.

    Frontiers in immunology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us